Severe respiratory illness drives people into hospitals. Many of them die.
For the fifth year running, Brazil's flu vaccination campaign has closed without reaching its own targets, leaving only 38 percent of its most vulnerable citizens protected as respiratory illness rises across nearly every state. The shortfall is not one of supply but of something harder to manufacture — trust, habit, and collective will. As Fiocruz signals alert levels nationwide and specialists warn of ICU wards filling with the elderly and immunocompromised, the country confronts a quiet but recurring failure: the distance between what public health requires and what daily life delivers.
- Brazil's flu campaign ended Saturday having vaccinated barely 17.4 million people from priority groups — children, the elderly, and pregnant women — against a target that would have required far more.
- Fiocruz data shows Severe Acute Respiratory Syndrome cases climbing across all age groups, with all states except Rondônia operating at alert level or above.
- Infectious disease specialists warn that these surging cases translate directly into ICU admissions and deaths, with the heaviest toll falling on those whose bodies are already most fragile.
- Cities like Belo Horizonte scrambled to open last-minute vaccination posts on the final day, but the nationwide pattern of low turnout held firm regardless.
- The Health Ministry will keep vaccines available beyond the official campaign's end, though sustained hesitancy — not shortage — remains the central obstacle to meaningful coverage.
Brazil's flu vaccination campaign closed on Saturday having reached only 38 percent of its target population — the fifth consecutive year the country has fallen short of its own immunization goals. Of the children under six, elderly citizens, and pregnant women most at risk of severe respiratory illness, only 17.4 million received doses when far more were needed.
In Belo Horizonte, health authorities opened nineteen vaccination posts on the final day in a last-minute effort to close the gap. Tatiani Fereguetti, who oversees health promotion and epidemiological surveillance for the city, stressed the urgency of protecting people as quickly as possible. But the pattern across the country was the same: low turnout, missed targets, and a growing recognition that voluntary uptake alone was proving insufficient.
The failure arrived at a particularly troubling moment. Fiocruz, Brazil's foremost public health research institute, reported that respiratory infections were rising across all age groups, with nearly every state — all except Rondônia — operating at alert level or higher. Infectious disease specialist Carlos Starling described the consequences plainly: severe acute respiratory syndrome fills hospitals, and it kills, with the heaviest burden falling on the elderly, the very young, and the immunocompromised.
The Health Ministry announced it would keep vaccines available at clinics after the campaign's official close — a quiet admission that the work remained unfinished. Some individuals, like retired woman Silvane Mansur, had made vaccination a personal routine and encouraged others to do the same. Even four-year-old Antonela Costa Inacio understood the essential bargain: the shot protects you, she said, and you get a lollipop.
Yet individual conviction could not bridge a broader gap between public health necessity and collective behavior. Whether continued vaccine availability would shift that pattern — or whether Brazil would face the next respiratory season as exposed as it faces this one — remained an open and pressing question.
The flu vaccination campaign in Brazil ended on Saturday having reached only 38 percent of its target population—a shortfall that marks the fifth consecutive year the country has failed to meet its immunization goals. The numbers tell a stark story: 17.4 million doses administered when far more were needed to protect children under six, elderly citizens, and pregnant women, the three groups most vulnerable to severe respiratory illness.
In Belo Horizonte, health authorities opened nineteen vaccination posts on the final day, a last-minute push to close the gap. Tatiani Fereguetti, who directs health promotion and epidemiological surveillance for the city, emphasized the urgency of the moment—that people needed to be protected as quickly as possible. But across the country, the same pattern held: low turnout, missed targets, and a growing sense that voluntary uptake alone would not be enough.
The timing of this failure is particularly troubling. Even as the vaccination campaign wound down, cases of Severe Acute Respiratory Syndrome were climbing. Fiocruz, Brazil's leading public health research institute, released data showing that respiratory infections were rising across all age groups. According to the InfoGripe bulletin, nearly every state in the country—all except Rondônia—was operating at alert level or higher, meaning the risk of serious illness was either present or acute.
Carlos Starling, an infectious disease specialist, laid out what this means in practical terms. Severe acute respiratory syndrome drives people into hospitals, he explained, and it hits the most vulnerable hardest. These patients need intensive care. Many of them die. The disease does not discriminate by age, but the consequences fall heaviest on those whose bodies are already compromised—the elderly, the very young, the immunocompromised.
Yet even with this backdrop, vaccination rates remained low. The gap between what public health officials knew was necessary and what the population was willing to do had widened year after year. This was not a problem of supply; it was a problem of demand, of trust, of competing priorities in people's daily lives.
The Health Ministry announced it would keep vaccines available at clinics and health posts even after the official campaign ended, a quiet acknowledgment that the work was not finished. Some people, like Silvane Mansur, a retired woman, understood the value and made vaccination part of her routine. She spoke of the vaccine's benefits to her own health and said she recommended it to others whenever she could. Even Antonela Costa Inacio, a four-year-old, grasped something of the logic: it protects you, she said, and you get a lollipop.
But individual choices, no matter how sensible, could not overcome a broader pattern of hesitation. The question now was whether the ministry's continued availability of vaccines would be enough to move the needle, or whether Brazil would enter the next respiratory illness season with the same vulnerability it faced now.
Notable Quotes
Severe acute respiratory syndrome drives people into hospitals, and it hits the most vulnerable hardest. These patients need intensive care. Many of them die.— Carlos Starling, infectious disease specialist
The vaccine has a good effect on me, so I recommend it and try to get vaccinated whenever I can.— Silvane Mansur, retired resident of Belo Horizonte
The Hearth Conversation Another angle on the story
Why does this matter so much that it's the fifth year in a row? Is it just about hitting a number?
It's not about the number itself. It's that each year the gap stays open, more people go unprotected. When you miss the target five times, you're not just behind—you're establishing a pattern that's hard to break.
But the Health Ministry says they'll keep vaccines available. Doesn't that solve it?
It keeps the door open, but it doesn't change why people didn't walk through it in the first place. The campaign had a deadline, resources, visibility. After it ends, it becomes background noise.
What's the actual risk here? Is this a crisis or a warning?
It's a warning that's already becoming a crisis. Fiocruz is reporting rising cases now, not predicting them. The vulnerable people—elderly, very young children—they're the ones who end up in intensive care. Some don't leave.
So why aren't people vaccinating? Is it distrust?
It could be distrust, but it could also be indifference, inconvenience, or simply not seeing the threat as real until it's at their door. A four-year-old understands it protects her. Adults have more complicated reasons for saying no.
Does this happen in other countries?
Vaccination campaigns everywhere struggle with uptake. But when you miss your target five years running, it suggests something structural—either the messaging isn't landing, or the population has decided the risk isn't worth the effort. Either way, it's a problem.